{"id":106998,"date":"2023-10-03T11:49:33","date_gmt":"2023-10-03T11:49:33","guid":{"rendered":"https:\/\/dailytalks.org\/?p=106998"},"modified":"2023-10-03T11:49:33","modified_gmt":"2023-10-03T11:49:33","slug":"concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=106998","title":{"rendered":"Concord Biotech shares list at a healthy premium. What should investors do?"},"content":{"rendered":"<p>Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.<br \/><a href=\"https:\/\/economictimes.indiatimes.com\/markets\/stocks\/news\/concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do\/articleshow\/102829822.cms\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across<\/p>\n","protected":false},"author":1,"featured_media":106999,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-106998","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106998-concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do.jpg",1070,580,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106998-concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do-150x150.jpg",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106998-concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do-300x163.jpg",300,163,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106998-concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do-768x416.jpg",640,347,true],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106998-concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do-1024x555.jpg",640,347,true],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106998-concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do.jpg",1070,580,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106998-concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do.jpg",1070,580,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106998-concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do-1024x555.jpg",1024,555,true],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106998-concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do-825x575.jpg",825,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/10\/106998-concord-biotech-shares-list-at-a-healthy-premium-what-should-investors-do-590x410.jpg",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=35\" rel=\"category\">Tech<\/a>","tag_info":"Tech","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/106998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=106998"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/106998\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/106999"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=106998"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=106998"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=106998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}